01 10Votrient
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 635
2019 Revenue in Millions : 755
Growth (%) : -16
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 577
2020 Revenue in Millions : 635
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 474
2021 Revenue in Millions : 577
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 390
2022 Revenue in Millions : 474
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : 23.90%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 0
2014 Revenue in Millions : 565
Growth (%) : New Launch
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 729
2015 Revenue in Millions : 565
Growth (%) : 29
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 808
2016 Revenue in Millions : 729
Growth (%) : 11
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 828
2017 Revenue in Millions : 808
Growth (%) : 2%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 755
2018 Revenue in Millions : 828
Growth (%) : -9
LOOKING FOR A SUPPLIER?